Gamil Othman
Impact in
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Pharmaceutical Quality and Counterfeiting 5
-
- Pharmaceutical Economics and Policy 6
- Co-authors
- Mahfoudh A. M. Abdulghani (3 shared papers)Abdulsalam Halboup (10 shared papers)Ali Assabri (1 shared paper)Yuri V. Bobryshev (1 shared paper)Waqar Al-Kubaisy (1 shared paper)Hassanain Al-Talib (1 shared paper)Karuthan Chinna (1 shared paper)Aqil Mohammad Daher (1 shared paper)
- Journals
- Patient Preference and Adherence (1 paper)BMC Health Services Research (1 paper)Vaccine (1 paper)Pharmacy Education (1 paper)International Journal of Applied Pharmaceutics (1 paper)
- Partner nations
- YemenSaudi ArabiaQatar
In The Last Decade
Gamil Othman
16 papers receiving 140 citations
Peers
Comparison fields: 5 of 53
- Toxicology 22
- Geriatrics and Gerontology 22
- Applied Microbiology and Biotechnology 11
- Research and Theory 2
- Family Practice 4
Countries citing papers authored by Gamil Othman
This map shows the geographic impact of Gamil Othman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamil Othman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamil Othman more than expected).
Fields of papers citing papers by Gamil Othman
This network shows the impact of papers produced by Gamil Othman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamil Othman. The network helps show where Gamil Othman may publish in the future.
Co-authors
The 25 scholars most cited alongside Gamil Othman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 46 | |
| 2 | 2017 | 16 | |
| 3 | 2020 | 14 | |
| 4 | Prevalence of Vitamin D Deficiency Between Type 2 Diabetes Mellitus Patients and Non-Diabetics in the Arab Gulf | 2022 | 13 |
| 5 | Assessment of knowledge and perceptions of generic medicines among pharmacy students in Yemeni universities | 2015 | 11 |
| 6 | 2022 | 8 | |
| 7 | 2021 | 7 | |
| 8 | 2017 | 6 | |
| 9 | 2022 | 5 | |
| 10 | 2017 | 4 | |
| 11 | 2016 | 3 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2016 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2018 | 0 | |
| 19 | 2024 | 0 | |
| 20 | 2021 | 0 |
About Gamil Othman
Gamil Othman is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics, General Health Professions, Pediatrics, Perinatology and Child Health and Applied Microbiology and Biotechnology, having authored 22 papers that have together received 144 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (6 papers), Pharmaceutical Quality and Counterfeiting (5 papers), Pharmaceutical studies and practices (3 papers), Antibiotic Use and Resistance (3 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Global Healthcare and Medical Tourism (2 papers) and Pharmaceutical industry and healthcare (2 papers). The work is most often cited by research in Toxicology (22 citations), Geriatrics and Gerontology (22 citations), Applied Microbiology and Biotechnology (11 citations), Research and Theory (2 citations) and Family Practice (4 citations). Gamil Othman has collaborated with scholars based in Yemen, Saudi Arabia and Qatar. Frequent co-authors include Mahfoudh A. M. Abdulghani, Abdulsalam Halboup, Ali Assabri, Yuri V. Bobryshev, Waqar Al-Kubaisy, Hassanain Al-Talib, Karuthan Chinna, Aqil Mohammad Daher, Alyaa Al-Khateeb and Redhwan Ahmed Al-Naggar. Their work appears in journals such as Patient Preference and Adherence, BMC Health Services Research, Vaccine, Pharmacy Education and International Journal of Applied Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.